Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Market Definitions
1.2. Estimates and Forecast Timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. GVR’s Internal Database
1.4.3. Secondary Sources & Third-Party Perspectives
1.4.4. Primary Research
1.5. Information Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Data Visualization
1.7. Model Details
1.8. List of Secondary Sources
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.4. Business Environment Analysis
3.4.1. PESTLE Analysis
3.4.2. Porter’s Five Forces Analysis
3.5. COVID-19 Impact Analysis
Chapter 4. Treatment Business Analysis
4.1. Ketamine Clinics Market: Treatment Movement Analysis & Market Share, 2022 & 2030
4.2. Depression
4.2.1. U.S. Depression Market, 2018 - 2030 (USD Million)
4.3. Anxiety
4.3.1. U.S. Anxiety Market, 2018 - 2030 (USD Million)
4.4. PTSD
4.4.1. U.S. PTSD Market, 2018 - 2030 (USD Million)
4.5. Others
4.5.1. U.S. Others Market, 2018 - 2030 (USD Million)
Chapter 5. Therapy Business Analysis
5.1. Ketamine Clinics Market: Therapy Movement Analysis & Market Share, 2022 & 2030
5.2. On-Site Therapy
5.2.1. U.S. On-Site Therapy Market, 2018 - 2030 (USD Million)
5.3. Online Therapy
5.3.1. U.S. Online Therapy Market, 2018 - 2030 (USD Million)
Chapter 6. Competitive Landscape
6.1. Company Categorization
6.2. Strategy Mapping
6.2.1. Expansion
6.2.2. Acquisition
6.2.3. Collaborations
6.2.4. New Product Launches
6.2.5. Others
6.3. Company Profiles/Listing
6.3.1. NY Ketamine Infusions
6.3.1.1. Overview
6.3.1.2. Financial Performance
6.3.1.3. Product Benchmarking
6.3.1.4. Strategic Initiatives
6.3.2. Field Trip Health and Wellness Ltd.
6.3.2.1. Overview
6.3.2.2. Financial Performance
6.3.2.3. Product Benchmarking
6.3.2.4. Strategic Initiatives
6.3.3. Ketamine Clinics Los Angeles
6.3.3.1. Overview
6.3.3.2. Financial Performance
6.3.3.3. Product Benchmarking
6.3.3.4. Strategic Initiatives
6.3.4. Klarity Clinic
6.3.4.1. Overview
6.3.4.2. Financial Performance
6.3.4.3. Product Benchmarking
6.3.4.4. Strategic Initiatives
6.3.5. Vitalitas Denver Ketamine Centers
6.3.5.1. Overview
6.3.5.2. Financial Performance
6.3.5.3. Product Benchmarking
6.3.5.4. Strategic Initiatives
6.3.6. Mindbloom, Inc
6.3.6.1. Overview
6.3.6.2. Financial Performance
6.3.6.3. Product Benchmarking
6.3.6.4. Strategic Initiatives
6.3.7. Nue Life Health
6.3.7.1. Overview
6.3.7.2. Financial Performance
6.3.7.3. Product Benchmarking
6.3.7.4. Strategic Initiatives
6.3.8. Better U, LLC
6.3.8.1. Overview
6.3.8.2. Financial Performance
6.3.8.3. Product Benchmarking
6.3.8.4. Strategic Initiatives
6.3.9. Innerwell
6.3.9.1. Overview
6.3.9.2. Financial Performance
6.3.9.3. Product Benchmarking
6.3.9.4. Strategic Initiatives
6.3.10. Klarisana
6.3.10.1. Overview
6.3.10.2. Financial Performance
6.3.10.3. Product Benchmarking
6.3.10.4. Strategic Initiatives
Chapter 7. Recommendations/Key Market Insights
List of Tables
Table 1. List of secondary sources
Table 2. List of abbreviations
Table 3. U.S. ketamine clinics market, by treatment, 2018 - 2030 (USD Million)
Table 4. U.S. ketamine clinics market, by therapy, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 US ketamine clinics market segmentation
Fig. 8 Market snapshot, 2022
Fig. 9 Segment snapshot
Fig. 10 Competitive landscape snapshot
Fig. 11 Market trends & outlook
Fig. 12 Market driver relevance analysis (current & future impact)
Fig. 13 Market restraint relevance analysis (current & future impact)
Fig. 14 PESTLE analysis
Fig. 15 Porter’s five forces analysis
Fig. 16 U.S. ketamine clinics market: Treatment outlook and key takeaways
Fig. 17 U.S. ketamine clinics market: Treatment movement analysis
Fig. 18 Depression market revenue, 2018 - 2030 (USD Million)
Fig. 19 Anxiety market revenue, 2018 - 2030 (USD Million)
Fig. 20 PTSD market revenue, 2018 - 2030 (USD Million)
Fig. 21 U.S. ketamine clinics market: Therapy outlook and key takeaways
Fig. 22 U.S. ketamine clinics market: Therapy movement analysis
Fig. 23 On-site therapy market revenue, 2018 - 2030 (USD Million)
Fig. 24 Online therapy market revenue, 2018 - 2030 (USD Million)
Fig. 25 Company categorization
Fig. 26 Strategy mapping
Fig. 27 Company market position analysis